Who Owns Palvella Therapeutics Stock?
NASDAQ: PVLAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 103.83%
- Institutions (% of float)
- 117.45%
- Held by insiders
- 11.60%
- Institutional holders
- 276
- Institutions 88.4%
- Insiders 11.6%
- Public and other 0.0%
Who owns Palvella Therapeutics stock?
Institutional investors own about 103.8% of Palvella Therapeutics's shares, spread across 276 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 11.60% of PVLA.
The largest institutional holders are Montanova Capital LLC (7.88%), Jennison Associates LLC (6.67%) and Blackrock Inc. (6.37%). Together, the top 10 institutions control 52.9% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their PVLA positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PVLA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Montanova Capital LLC | 1.14M | 7.88% | -1.6% |
| Jennison Associates LLC | 960.62K | 6.67% | +50.0% |
| Blackrock Inc. | 918.36K | 6.37% | +33.7% |
| Frazier Life Sciences Management, L.P. | 882.40K | 6.12% | 0.0% |
| First Light Asset Management, LLC | 771.90K | 5.36% | -21.3% |
| BVF Inc. | 672.79K | 4.67% | -30.0% |
| State Street Corporation | 653.17K | 4.53% | +42.3% |
| Price (T.Rowe) Associates Inc | 638.87K | 4.43% | +58.7% |
| Vanguard Capital Management LLC | 513.79K | 3.57% | +7.7% |
| Frontier Capital Management Company LLC | 478.83K | 3.32% | +28.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PVLA
| Fund | Shares | % Held |
|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 431.53K | 2.99% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 388.39K | 2.70% |
| iShares Trust-iShares Russell 2000 ETF | 279.12K | 1.94% |
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund | 276.56K | 1.92% |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 231.48K | 1.61% |
| PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund | 209.82K | 1.46% |
| Prudential Jennison Small Co Fd., Inc.-PGIM JENNISON SMALL COMPANY Fd. | 202.90K | 1.41% |
| Prudential Sector Funds, Inc.-PGIM Jennison Health Sciences Fund | 183.04K | 1.27% |
| T. Rowe Price New Horizons Fund, Inc. | 164.14K | 1.14% |
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund | 150.50K | 1.04% |
Frequently asked questions
Who is the largest shareholder of Palvella Therapeutics?
Montanova Capital LLC is the largest institutional shareholder of PVLA, owning 7.88% of shares outstanding (1.14M shares) as of its latest 13F filing.
What percentage of Palvella Therapeutics is owned by institutions?
Institutions own about 103.8% of PVLA shares and 117.5% of the public float.
How much of Palvella Therapeutics do insiders own?
Insiders, such as officers and directors, own about 11.60% of PVLA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.